HomeCGTX • NASDAQ
add
Cognition Therapeutics Inc
Previous close
$0.76
Day range
$0.77 - $0.96
Year range
$0.22 - $3.83
Market cap
79.60M USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.67M | 27.49% |
Net income | -3.34M | 57.37% |
Net profit margin | — | — |
Earnings per share | -0.02 | 88.24% |
EBITDA | -13.66M | -27.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.81M | 47.19% |
Total assets | 48.39M | 60.05% |
Total liabilities | 14.12M | 22.94% |
Total equity | 34.27M | — |
Shares outstanding | 89.35M | — |
Price to book | 1.95 | — |
Return on assets | -74.47% | — |
Return on capital | -95.18% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.34M | 57.37% |
Cash from operations | -3.44M | 59.00% |
Cash from investing | 9.00K | 1,000.00% |
Cash from financing | 605.00K | -94.68% |
Net change in cash | -2.82M | -194.16% |
Free cash flow | -8.77M | -14.21% |
About
Founded
Jan 1, 2007
Website
Employees
14
